I agree that this site is using cookies. You can find further informations here.
X
Czuczman, Cory
19  results:
Search for persons X
?
1

No differences in delay discounting between smokers with an..:

Czuczman, Cory ; Thompson, Morgan ; Wileyto, E. Paul...
Psychopharmacology.  238 (2020)  2 - p. 529-537 , 2020
Link: https://doi.org/10.1007/..
 
?
2

No differences in delay discounting between smokers with an..:

Czuczman, Cory ; Thompson, Morgan ; Wileyto, E. Paul...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855959/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
3

Initial Exploration of a New Tool to Quickly and Automatica..:

Daniel Smith ; Cory Czuczman ; Felicia Hurewitz
doi:10.5281/zenodo.8147430.  , 2014
Link: https://zenodo.org/recor..
 
?
4

Peg-filgrastim potentiates rituximab in patients with indol..:

Torka, Pallawi ; Patel, Priyank ; Tan, Wei...
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. S72 , 2015
Link: https://doi.org/10.1016/..
 
?
5

A Phase II Trial of Rituximab Combined With Pegfilgrastim i..:

Torka, Pallawi ; Patel, Priyank ; Tan, Wei...
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  1 - p. e51-e60 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Up-regulation of hexokinase II contributes to rituximab-che..:

Gu, Juan J. ; Singh, Anil ; Xue, Kai...
Oncotarget.  9 (2017)  3 - p. 4020-4033 , 2017
Link: https://doi.org/10.18632..
 
?
7

Mitotic catastrophe and cell cycle arrest are alternative c..:

Gu, Juan J. ; Kaufman, Gregory P. ; Mavis, Cory..
Oncotarget.  8 (2016)  8 - p. 12741-12753 , 2016
Link: https://doi.org/10.18632..
 
?
8

Entinostat, a novel histone deacetylase inhibitor is active..:

Frys, Sarah ; Simons, Zachary ; Hu, Qiang...
British Journal of Haematology.  169 (2015)  4 - p. 506-519 , 2015
Link: https://doi.org/10.1111/..
 
?
9

Vorinostat, a histone deacetylase (HDAC) inhibitor, promote..:

Xue, Kai ; Gu, Juan J. ; Zhang, Qunling...
Journal of Cancer Research and Clinical Oncology.  142 (2015)  2 - p. 379-387 , 2015
Link: https://doi.org/10.1007/..
 
?
10

The novel proteasome inhibitor carfilzomib induces cell cyc..:

Gu, Juan J. ; Hernandez‐Ilizaliturri, Francisco J. ; Kaufman, Gregory P....
British Journal of Haematology.  162 (2013)  5 - p. 657-669 , 2013
Link: https://doi.org/10.1111/..
 
?
11

Distinct cellular and therapeutic effects of obatoclax in r..:

Brem, Elizabeth A. ; Thudium, Karen ; Khubchandani, Sapna...
British Journal of Haematology.  153 (2011)  5 - p. 599-611 , 2011
Link: https://doi.org/10.1111/..
 
?
12

Ofatumumab demonstrates activity against rituximab‐sensitiv..:

Barth, Matthew J. ; Hernandez‐Ilizaliturri, Francisco J. ; Mavis, Cory...
British Journal of Haematology.  156 (2011)  4 - p. 490-498 , 2011
Link: https://doi.org/10.1111/..
 
?
13

Pevonedistat, a NEDD8-activating enzyme inhibitor, is activ..:

Czuczman, Natalie M ; Barth, Matthew J ; Gu, Juan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778163/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
14

Entinostat, a novel histone deacetylase inhibitor is active..:

Frys, Sarah ; Simons, Zachary ; Hu, Qiang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802357/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
15

Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity ..:

Barth, Matthew J ; Mavis, Cory ; Czuczman, Myron S.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685505/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
1-15